Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays.
Afonso J, Lopes S, Gonçalves R, Caldeira P, Lago P, Tavares de Sousa H, Ramos J, Gonçalves AR, Ministro P, Rosa I, Vieira AI, Coelho R, Tavares P, Soares J, Sousa AL, Carvalho D, Sousa P, da Silva JP, Meira T, Silva Ferreira F, Dias CC, Chowers Y, Ben-Horin S, Magro F; on behalf Portuguese IBD Study Group (GEDII). Afonso J, et al. Among authors: caldeira p. Therap Adv Gastroenterol. 2016 Nov;9(6):781-794. doi: 10.1177/1756283X16658223. Epub 2016 Jul 26. Therap Adv Gastroenterol. 2016. PMID: 27803733 Free PMC article.
Inflammatory bowel disease: a patient's and caregiver's perspective.
Magro F, Portela F, Lago P, Deus J, Cotter J, Cremers I, Vieira A, Peixe P, Caldeira P, Lopes H, Gonçalves R, Reis J, Cravo M, Barros L, Ministro P, Lurdes Tavares M, Duarte A, Campos M, Carvalho L; Portuguese Study Group of IBD (GEDII); Association of Portuguese Patients with IBD (APDI). Magro F, et al. Among authors: caldeira p. Dig Dis Sci. 2009 Dec;54(12):2671-9. doi: 10.1007/s10620-008-0658-3. Dig Dis Sci. 2009. PMID: 19130226
Crohn's disease in a southern European country: Montreal classification and clinical activity.
Magro F, Portela F, Lago P, Ramos de Deus J, Vieira A, Peixe P, Cremers I, Cotter J, Cravo M, Tavares L, Reis J, Gonçalves R, Lopes H, Caldeira P, Ministro P, Carvalho L, Azevedo L, da Costa-Pereira A; GEDII. Magro F, et al. Among authors: caldeira p. Inflamm Bowel Dis. 2009 Sep;15(9):1343-50. doi: 10.1002/ibd.20901. Inflamm Bowel Dis. 2009. PMID: 19235885
Ulcerative colitis in a Southern European country: a national perspective.
Portela F, Magro F, Lago P, Cotter J, Cremers I, de Deus J, Vieira A, Lopes H, Caldeira P, Barros L, Reis J, Carvalho L, Gonçalves R, Campos MJ, Ministro P, Duarte MA, Amil J, Rodrigues S, Azevedo L, Costa-Pereira A. Portela F, et al. Among authors: caldeira p. Inflamm Bowel Dis. 2010 May;16(5):822-9. doi: 10.1002/ibd.21119. Inflamm Bowel Dis. 2010. PMID: 19824069 Free article.
Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA study II).
Durães C, Machado JC, Portela F, Rodrigues S, Lago P, Cravo M, Ministro P, Marques M, Cremers I, Freitas J, Cotter J, Tavares L, Matos L, Medeiros I, Sousa R, Ramos J, Deus J, Caldeira P, Chagas C, Duarte MA, Gonçalves R, Loureiro R, Barros L, Bastos I, Cancela E, Moraes MC, Moreira MJ, Vieira AI, Magro F. Durães C, et al. Among authors: caldeira p. Inflamm Bowel Dis. 2013 Feb;19(2):230-9. doi: 10.1002/ibd.23007. Inflamm Bowel Dis. 2013. PMID: 22573572
Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study.
Magro F, Lopes S, Coelho R, Cotter J, Dias de Castro F, Tavares de Sousa H, Salgado M, Andrade P, Vieira AI, Figueiredo P, Caldeira P, Sousa A, Duarte MA, Ávila F, Silva J, Moleiro J, Mendes S, Giestas S, Ministro P, Sousa P, Gonçalves R, Gonçalves B, Oliveira A, Chagas C, Torres J, Dias CC, Lopes J, Borralho P, Afonso J, Geboes K, Carneiro F; Portuguese IBD Study Group [GEDII]. Magro F, et al. Among authors: caldeira p. J Crohns Colitis. 2017 Apr 1;11(4):435-444. doi: 10.1093/ecco-jcc/jjw170. J Crohns Colitis. 2017. PMID: 27664275
Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions.
Dias CC, Rodrigues PP, Coelho R, Santos PM, Fernandes S, Lago P, Caetano C, Rodrigues Â, Portela F, Oliveira A, Ministro P, Cancela E, Vieira AI, Barosa R, Cotter J, Carvalho P, Cremers I, Trabulo D, Caldeira P, Antunes A, Rosa I, Moleiro J, Peixe P, Herculano R, Gonçalves R, Gonçalves B, Sousa HT, Contente L, Morna H, Lopes S, Magro F; on behalf GEDII. Dias CC, et al. Among authors: caldeira p. J Crohns Colitis. 2017 Apr 1;11(4):445-453. doi: 10.1093/ecco-jcc/jjw171. J Crohns Colitis. 2017. PMID: 27683799
96 results